Literature DB >> 8513397

Multiple sclerosis. Pathology of recurrent lesions.

J W Prineas1, R O Barnard, T Revesz, E E Kwon, L Sharer, E S Cho.   

Abstract

Recent autopsy studies suggest that remyelinated shadow plaques located in otherwise intact white matter are the outcome of a previous single episode of acute demyelination. In the present study, of 98 remyelinated plaques examined in 15 patients with multiple sclerosis who died between 27 days and 5 years after clinical onset, 15 showed evidence of a superimposed new demyelinating lesion. Inspection of old shadow plaques in a separate series of patients with subacute and long-standing multiple sclerosis revealed that such lesions sometimes exhibit punched-out areas of demyelination and gliosis similar in size and shape to fresh lesions located within or overlapping remyelinated shadow plaques. The findings support magnetic resonance imaging evidence that local recurrence may be as important or more important than progressive edge activity in determining plaque growth and the conversion of nascent lesions into classical demyelinated plaques. The findings also support experimental evidence that recurrent demyelination of the same area of white matter may be one of the factors underlying failed remyelination in multiple sclerosis.

Entities:  

Mesh:

Year:  1993        PMID: 8513397     DOI: 10.1093/brain/116.3.681

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  40 in total

1.  Variation of visual evoked potential delay to stimulation of central, nasal, and temporal regions of the macula in optic neuritis.

Authors:  S Rinalduzzi; A Brusa; S J Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

Review 2.  Early-stage multiple sclerosis : what are the treatment options?

Authors:  Per Soelberg Sorensen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.

Authors:  Z Campbell; D Sahm; K Donohue; J Jamison; M Davis; C Pellicano; S Auh; J Ohayon; J A Frank; N Richert; F Bagnato
Journal:  Neurology       Date:  2012-04-25       Impact factor: 9.910

Review 4.  Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.

Authors:  J H Simon
Journal:  West J Med       Date:  1996-06

Review 5.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

6.  Conduction in segmentally demyelinated mammalian central axons.

Authors:  P A Felts; T A Baker; K J Smith
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

7.  Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis.

Authors:  J Zhang; Z G Zhang; D Morris; Y Li; C Roberts; S B Elias; M Chopp
Journal:  Neuroscience       Date:  2009-09-25       Impact factor: 3.590

Review 8.  Oligodendrocytes: biology and pathology.

Authors:  Monika Bradl; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2009-10-22       Impact factor: 17.088

9.  Benign form of multiple sclerosis: MRI evidence for less frequent and less inflammatory disease activity.

Authors:  D Kidd; A J Thompson; B E Kendall; D H Miller; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

Review 10.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.